Preliminary results of first-in-human dose escalation of VLP peanut in healthy subjects

Authors
Category Primary study
ConferenceEuropean Academy of Allergy and Clinical Immunology Hybrid Congress
Year 2024
This article has no abstract
Epistemonikos ID: ab5bc91f638addfd4f24c8991b316273a05a6662
First added on: Jan 31, 2026